Pfizer (UKEX:PFE) Cyclically Adjusted Book per Share: ₴673.33 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:PFE Pfizer Inc UKEX:PFE
67 GF Score
Price ₴1,014.00
GF Value ₴958.01
! 8 Warning Signs
View Full Analysis

What is Pfizer Cyclically Adjusted Book per Share?

Pfizer UKEX:PFE 67 Cyclically Adjusted Book per Share is ₴673.33 as of Jun. 2026. GuruFocus rates UKEX:PFE with a GF Score™ of 67/100 and a GF Value™ of ₴958.01. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pfizer's adjusted book value per share for the three months ended in Jun. 2026 was ₴668.664. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₴673.33 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Pfizer's average Cyclically Adjusted Book Growth Rate was 4.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pfizer was 27.40% per year. The lowest was 0.90% per year. And the median was 8.00% per year.

As of today (2026-08-22), Pfizer's current stock price is ₴1014.00. Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ₴673.33. Pfizer's Cyclically Adjusted PB Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.44. And the median was 2.85.


Pfizer  (UKEX:PFE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pfizer's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1014.00/673.33
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.44. And the median was 2.85.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pfizer Cyclically Adjusted Book per Share Related Terms


Pfizer Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pfizer's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Cyclically Adjusted Book per Share Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 551.63 571.40 629.58

Pfizer Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 641.28 616.04 629.58 570.56 673.33

UKEX:PFE vs BMY, GILD, AMGN: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.


UKEX:PFE
67GF Score
Pfizer Inc UKEX:PFE
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=668.664/333.9520*333.9520
=668.664

Current CPI (Jun. 2026) = 333.9520.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201609 466.502 241.428 645.283
201612 438.658 241.432 606.758
201703 438.796 243.801 601.051
201706 438.866 244.955 598.315
201709 455.917 246.819 616.867
201712 533.376 246.524 722.534
201803 527.650 249.554 706.099
201806 532.343 251.989 705.495
201809 551.787 252.439 729.960
201812 496.010 251.233 659.322
201903 473.252 254.202 621.724
201906 478.963 256.143 624.458
201909 526.416 256.759 684.680
201912 510.294 256.974 663.155
202003 523.812 258.115 677.714
202006 518.203 257.797 671.284
202009 525.353 260.280 674.054
202012 508.169 260.474 651.520
202103 548.757 264.877 691.863
202106 559.628 271.696 687.860
202109 603.470 274.310 734.680
202112 614.523 278.802 736.082
202203 659.501 287.504 766.047
202206 697.530 296.311 786.139
202209 738.397 296.808 830.804
202212 762.008 296.797 857.401
202303 800.199 301.836 885.342
202306 784.704 305.109 858.885
202309 768.045 307.789 833.331
202312 705.292 306.746 767.846
202403 728.476 312.332 778.902
202406 692.355 314.175 735.938
202409 728.636 315.301 771.737
202412 696.278 315.605 736.755
202503 710.872 319.799 742.332
202506 697.898 322.561 722.544
202509 730.183 324.800 750.758
202512 680.362 324.054 701.143
202603 707.265 330.213 715.273
202606 668.664 333.952 668.664

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₴673.33 mean?
Pfizer (UKEX:PFE) has a Cyclically Adjusted Book per Share of ₴673.33 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pfizer and its competitors.
Is Pfizer's Cyclically Adjusted Book per Share too high?
Pfizer's current Cyclically Adjusted Book per Share is ₴673.33. Overall, Pfizer has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Cyclically Adjusted Book per Share compare to BMY and GILD?
Pfizer's Cyclically Adjusted Book per Share of ₴673.33 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pfizer and its competitors. Pfizer's current Cyclically Adjusted Book per Share is ₴673.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Pfizer (UKEX:PFE) has a current Cyclically Adjusted Book per Share of ₴673.33. The stock's GF Value™ is ₴958.01, compared to a current price of ₴1,014.00 — trading 5.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₴673.33. Pfizer's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pfizer (UKEX:PFE), the current Cyclically Adjusted Book per Share is ₴673.33 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (UKEX:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be overvalued. The current stock price of ₴1,014.00 is trading 5.8% above its estimated GF Value™ of ₴958.01.

Key valuation signals for UKEX:PFE:

  • Cyclically Adjusted Book per Share: ₴673.33
  • GF Value™: ₴958.01 vs. price of ₴1,014.00 (5.8% above fair value)
  • GF Score™: 67/100 with 8 warning signs

No single metric tells the full story. See the UKEX:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
67GF Score

Get the complete analysis for UKEX:PFE

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴1,014.00
Price
₴958.01
GF Value